Episode 52
Biotech Hangout
00:00
The Negative Signals of Mergers
adaptive immune is not about to be bought by a big pharma right because if they were they wouldn't be doing this deal. The financing has a positive signal which is we need to finance and look companies signal all the time. We just have to be aware of you know the the reaction of the market to a merger isn't always a read on the fundamental implications of that mergerYeah it's a very fair point Tim. It would just be a little less frustrating if the the requires to to go trade down the name cage to value creative transactions, he says.
Transcript
Play full episode
